{
    "hands_on_practices": [
        {
            "introduction": "Quantitative Systems Pharmacology (QSP) models are often built upon the foundation of pharmacokinetic compartment models. A crucial first step in analyzing these systems is to understand their long-term behavior under continuous drug administration. This exercise  guides you through a fundamental analysis of a two-compartment model to determine the steady-state concentration ($C_{ss}$), the point at which the rate of drug administration is perfectly balanced by the rate of elimination. By solving the system's governing differential equations at equilibrium, you will uncover the key parameters that dictate chronic drug exposure, a cornerstone concept in determining dosing regimens.",
            "id": "5053528",
            "problem": "Consider a two-compartment drug distribution model used in Quantitative Systems Pharmacology (QSP), where drug is administered by constant intravenous infusion into the central compartment. Let the central compartment have volume $V_{1}$ and the peripheral compartment have volume $V_{2}$. Denote the amounts of drug in the central and peripheral compartments by $A_{1}(t)$ and $A_{2}(t)$, respectively, and the corresponding concentrations by $C_{1}(t) = A_{1}(t)/V_{1}$ and $C_{2}(t) = A_{2}(t)/V_{2}$. Drug elimination from the central compartment is characterized by a systemic clearance $CL$, and bidirectional distribution between the central and peripheral compartments is characterized by an intercompartmental clearance $Q$. The drug is infused into the central compartment at a constant rate $R_{0}$.\n\nStarting from conservation of mass and the definition of linear clearance-driven flows, the governing ordinary differential equations (ODEs) for the amounts are:\n$$\n\\frac{dA_{1}}{dt} = R_{0} - CL \\, C_{1}(t) - Q \\, C_{1}(t) + Q \\, C_{2}(t),\n$$\n$$\n\\frac{dA_{2}}{dt} = Q \\, C_{1}(t) - Q \\, C_{2}(t).\n$$\nAssume that steady state is achieved under the constant infusion. Compute the steady-state central compartment concentration $C_{ss} = C_{1}(\\infty)$ by solving $\\frac{dA_{1}}{dt} = 0$ and $\\frac{dA_{2}}{dt} = 0$ for $C_{ss}$ in terms of $R_{0}$, $CL$, $Q$, $V_{1}$, and $V_{2}$. Present your final answer as a single closed-form analytic expression and express the concentration in $\\mathrm{mg/L}$. No numerical evaluation or rounding is required.",
            "solution": "The problem asks for the steady-state central compartment concentration, $C_{ss}$, in a two-compartment pharmacokinetic model with constant intravenous infusion.\n\n### Step 1: Problem Validation\n\nFirst, a critical validation of the problem statement is performed.\n\n**1.1. Extracted Givens:**\n- **Model:** Two-compartment pharmacokinetic model.\n- **Compartment Volumes:** Central compartment volume $V_{1}$, peripheral compartment volume $V_{2}$.\n- **Drug Amounts:** $A_{1}(t)$ in central, $A_{2}(t)$ in peripheral.\n- **Concentrations:** $C_{1}(t) = A_{1}(t)/V_{1}$, $C_{2}(t) = A_{2}(t)/V_{2}$.\n- **Infusion Rate:** Constant rate $R_{0}$ into the central compartment.\n- **Clearance Parameters:** Systemic clearance $CL$, intercompartmental clearance $Q$.\n- **Governing Ordinary Differential Equations (ODEs):**\n$$\n\\frac{dA_{1}}{dt} = R_{0} - CL \\, C_{1}(t) - Q \\, C_{1}(t) + Q \\, C_{2}(t)\n$$\n$$\n\\frac{dA_{2}}{dt} = Q \\, C_{1}(t) - Q \\, C_{2}(t)\n$$\n- **Objective:** Compute the steady-state central compartment concentration $C_{ss} = C_{1}(\\infty)$.\n- **Condition:** Steady state is defined by $\\frac{dA_{1}}{dt} = 0$ and $\\frac{dA_{2}}{dt} = 0$.\n- **Required Parameters in Solution:** The solution for $C_{ss}$ should be in terms of $R_{0}$, $CL$, $Q$, $V_{1}$, and $V_{2}$.\n\n**1.2. Validation against Criteria:**\n- **Scientific Grounding:** The problem describes a standard, widely used two-compartment model in pharmacokinetics and quantitative systems pharmacology. The equations are based on the principle of mass conservation. The model is scientifically sound.\n- **Well-Posedness:** The problem asks for the steady-state solution of a system of linear ODEs. This translates to solving a system of linear algebraic equations, which is a well-posed mathematical task that yields a unique solution.\n- **Objectivity:** The problem is stated using precise and unambiguous technical language. All variables and parameters are clearly defined.\n- **Completeness and Consistency:** All necessary equations and conditions are provided to find the solution. The problem requests the answer in terms of parameters $R_{0}$, $CL$, $Q$, $V_{1}$, and $V_{2}$. It may turn out that the final expression does not depend on all these parameters, but this is a result of the system's properties, not an inconsistency in the problem statement. The problem does not state that the final expression *must* contain all these variables.\n- **Other Flaws:** The problem is free from factual errors, unrealistic conditions, or logical fallacies.\n\n**1.3. Verdict:**\nThe problem is deemed **valid**. It is a well-defined, scientifically grounded problem in pharmacokinetics.\n\n### Step 2: Derivation of the Solution\n\nWe are tasked with finding the steady-state concentration in the central compartment, $C_{ss}$, which is defined as $C_{1}(t)$ as $t \\to \\infty$. At steady state, the amount of drug in each compartment is constant, which implies that the time derivatives of the amounts are zero.\n\nLet $C_{1,ss}$ and $C_{2,ss}$ be the steady-state concentrations in the central and peripheral compartments, respectively. The problem defines $C_{ss} = C_{1,ss}$. The steady-state condition is:\n$$\n\\frac{dA_{1}}{dt} = 0\n$$\n$$\n\\frac{dA_{2}}{dt} = 0\n$$\n\nApplying this condition to the given system of ODEs, we obtain a system of algebraic equations:\n$$\n0 = R_{0} - CL \\, C_{1,ss} - Q \\, C_{1,ss} + Q \\, C_{2,ss} \\quad \\quad (1)\n$$\n$$\n0 = Q \\, C_{1,ss} - Q \\, C_{2,ss} \\quad \\quad (2)\n$$\n\nWe can solve this system for $C_{1,ss}$. From equation $(2)$, we have:\n$$\nQ \\, C_{1,ss} = Q \\, C_{2,ss}\n$$\nAssuming that $Q > 0$ (a non-zero intercompartmental clearance is required for a two-compartment model to be distinct from a one-compartment model), we can divide both sides by $Q$:\n$$\nC_{1,ss} = C_{2,ss}\n$$\nThis result is physically intuitive: at steady state under a constant infusion, the drug has distributed throughout the system to the point where the concentrations in the connected compartments are equal, leading to zero net flux between them.\n\nNow, we substitute the result $C_{2,ss} = C_{1,ss}$ into equation $(1)$:\n$$\n0 = R_{0} - CL \\, C_{1,ss} - Q \\, C_{1,ss} + Q \\, C_{1,ss}\n$$\nThe terms involving the intercompartmental clearance, $- Q \\, C_{1,ss}$ and $+ Q \\, C_{1,ss}$, cancel each other out:\n$$\n0 = R_{0} - CL \\, C_{1,ss}\n$$\nThis simplified equation states that at steady state, the rate of drug infusion ($R_{0}$) is exactly balanced by the rate of drug elimination ($CL \\, C_{1,ss}$).\n\nFinally, we solve for $C_{1,ss}$:\n$$\nCL \\, C_{1,ss} = R_{0}\n$$\n$$\nC_{1,ss} = \\frac{R_{0}}{CL}\n$$\nSince the problem defines $C_{ss} = C_{1,ss}$, the final expression is:\n$$\nC_{ss} = \\frac{R_{0}}{CL}\n$$\nThe steady-state concentration depends only on the infusion rate and the systemic clearance. The parameters $Q$, $V_{1}$, and $V_{2}$ influence the dynamics of how the system approaches steady state but do not affect the value of the steady-state concentration itself. The final expression is a closed-form analytic expression as requested. The instruction to \"express the concentration in $\\mathrm{mg/L}$\" is interpreted as specifying the physical units of the quantity $C_{ss}$, which depends on the units chosen for $R_0$ and $CL$, and does not require inclusion of units in the final mathematical expression.",
            "answer": "$$\\boxed{\\frac{R_{0}}{CL}}$$"
        },
        {
            "introduction": "Moving beyond phenomenological compartments, QSP and Physiologically Based Pharmacokinetic (PBPK) models aim to represent drug distribution with greater mechanistic detail. A key element is modeling drug exchange between blood and tissue, a process limited by two distinct physical phenomena: the rate of drug delivery via blood flow ($Q$) and the rate of transport across the capillary wall, quantified by the permeability-surface area product ($PS$). This practice  challenges you to derive the effective tissue clearance ($CL_{\\text{tissue}}$) from first principles, revealing how it elegantly unifies these two limiting factors. This derivation is essential for understanding and predicting whether a drug's tissue uptake is perfusion-limited or permeability-limited, a critical determinant of its overall distribution profile.",
            "id": "5053584",
            "problem": "In a physiologically based tissue module used in Quantitative Systems Pharmacology (QSP), consider a single well-stirred capillary–tissue exchange unit for a passively distributed small molecule without metabolism in the tissue. Let the volumetric blood flow to the tissue be $Q$ and the endothelium permeability–surface product be $PS$. Assume the following physically grounded statements:\n- Conservation of mass in the capillary segment gives $Q\\,(C_{a}(t) - C_{v}(t))$ equals the net diffusive flux across the endothelium into tissue at time $t$, where $C_{a}(t)$ and $C_{v}(t)$ are the arterial and venous unbound plasma concentrations, respectively.\n- The diffusive flux across the endothelial barrier is proportional to the unbound concentration driving force across the barrier. If the unbound tissue-to-plasma partition coefficient at equilibrium is $K_{p}$, then the driving difference across the barrier is $C_{p,u} - C_{t,u}/K_{p}$, where $C_{p,u}$ is the capillary plasma unbound concentration and $C_{t,u}$ is the tissue unbound concentration. Under a well-stirred capillary assumption, take $C_{p,u} = C_{v}(t)$.\n- The total tissue amount $A_{t}(t)$ changes according to the endothelial diffusive flux, with $dA_{t}/dt$ equal to that flux. Define the effective tissue clearance $CL_{\\text{tissue}}$ by the linear relation\n$$\n\\frac{dA_{t}}{dt} \\equiv CL_{\\text{tissue}}\\,\\big(C_{a}(t) - \\frac{C_{t,u}(t)}{K_{p}}\\big),\n$$\nso that $CL_{\\text{tissue}}$ lumps the combined limitations from perfusion and permeability into a single first-order exchange coefficient multiplying the canonical driving force that vanishes at distribution equilibrium $C_{t,u} = K_{p}\\,C_{a}$.\n\nStarting only from conservation of mass and the definition of diffusive flux stated above (do not invoke any pre-derived clearance formulas), derive a closed-form analytic expression for $CL_{\\text{tissue}}$ in terms of $PS$, $Q$, and $K_{p}$ only. As part of your reasoning, determine which regime dominates exchange by comparing $PS$ and $Q$ and state the criterion demarcating perfusion-limited versus permeability-limited behavior. For interpretability, you may assume $C_{a}(t)$ varies slowly relative to capillary transit so that a quasi-steady capillary approximation is appropriate at each instant.\n\nYour final answer must be a single analytic expression for $CL_{\\text{tissue}}$ in terms of $PS$, $Q$, and $K_{p}$. Do not include any units or numerical evaluation in your final answer. If you choose to illustrate the regime classification with example values, do not report those values in the final boxed answer.",
            "solution": "The problem asks for the derivation of an expression for the effective tissue clearance, $CL_{\\text{tissue}}$, in a well-stirred capillary–tissue exchange unit, based on fundamental principles of mass transport. The derivation must start from the provided statements about mass conservation and diffusive flux.\n\nThe given principles are:\n1.  Conservation of mass in the capillary segment, under a quasi-steady state approximation, states that the rate of drug removal from the blood as it transits the capillary is equal to the net diffusive flux into the tissue. This is expressed as:\n    $$Q \\left( C_{a}(t) - C_{v}(t) \\right) = \\text{Net Diffusive Flux}$$\n    Here, $Q$ is the volumetric blood flow, $C_{a}(t)$ is the arterial unbound plasma concentration entering the capillary, and $C_{v}(t)$ is the venous unbound plasma concentration leaving the capillary.\n\n2.  The net diffusive flux across the endothelial barrier is proportional to the permeability–surface area product, $PS$, and the concentration gradient across the barrier. The driving force is specified as $C_{p,u} - C_{t,u}/K_{p}$, where $C_{p,u}$ is the capillary plasma unbound concentration, $C_{t,u}(t)$ is the tissue unbound concentration, and $K_{p}$ is the unbound tissue-to-plasma partition coefficient.\n    $$\\text{Net Diffusive Flux} = PS \\left( C_{p,u} - \\frac{C_{t,u}(t)}{K_{p}} \\right)$$\n\n3.  The model assumes a well-stirred capillary, which implies that the concentration within the capillary is uniform and equal to the leaving concentration. Therefore, the capillary plasma unbound concentration $C_{p,u}$ is taken to be the venous concentration $C_{v}(t)$.\n    $$C_{p,u} = C_{v}(t)$$\n\n4.  The rate of change of the total amount of drug in the tissue, $A_{t}(t)$, is equal to the net diffusive flux from the capillary.\n    $$\\frac{dA_{t}(t)}{dt} = \\text{Net Diffusive Flux}$$\n\n5.  Finally, an effective tissue clearance, $CL_{\\text{tissue}}$, is defined by the following relationship, which frames the tissue uptake rate in terms of a clearance parameter multiplying a systemic driving force:\n    $$\\frac{dA_{t}(t)}{dt} \\equiv CL_{\\text{tissue}} \\left( C_{a}(t) - \\frac{C_{t,u}(t)}{K_{p}} \\right)$$\n\nOur goal is to find an expression for $CL_{\\text{tissue}}$ in terms of $Q$, $PS$, and $K_{p}$.\n\nFirst, we combine the fundamental principles to obtain an expression for the net flux. Substituting the well-stirred assumption (3) into the diffusive flux equation (2), we get:\n$$\\text{Net Diffusive Flux} = PS \\left( C_{v}(t) - \\frac{C_{t,u}(t)}{K_{p}} \\right)$$\nLet's call this Equation (A).\n\nFrom the capillary mass balance (1), we have another expression for the flux:\n$$\\text{Net Diffusive Flux} = Q \\left( C_{a}(t) - C_{v}(t) \\right)$$\nLet's call this Equation (B).\n\nSince both Equation (A) and Equation (B) describe the same net flux, we can set them equal to each other:\n$$Q \\left( C_{a}(t) - C_{v}(t) \\right) = PS \\left( C_{v}(t) - \\frac{C_{t,u}(t)}{K_{p}} \\right)$$\nThe definition of $CL_{\\text{tissue}}$ (5) relates the net flux to $C_{a}(t)$ and $C_{t,u}(t)$. To align our derived flux expression with this definition, we must eliminate the intermediate variable $C_{v}(t)$. We rearrange the equation above to solve for $C_{v}(t)$:\n$$Q C_{a}(t) - Q C_{v}(t) = PS C_{v}(t) - PS \\frac{C_{t,u}(t)}{K_{p}}$$\n$$Q C_{a}(t) + PS \\frac{C_{t,u}(t)}{K_{p}} = (Q + PS) C_{v}(t)$$\n$$C_{v}(t) = \\frac{Q C_{a}(t) + PS \\frac{C_{t,u}(t)}{K_{p}}}{Q + PS}$$\n\nNow, we substitute this expression for $C_{v}(t)$ back into one of the flux equations, for instance, Equation (B):\n$$\\text{Net Diffusive Flux} = Q \\left( C_{a}(t) - \\frac{Q C_{a}(t) + PS \\frac{C_{t,u}(t)}{K_{p}}}{Q + PS} \\right)$$\nTo simplify, we find a common denominator for the term in the parenthesis:\n$$\\text{Net Diffusive Flux} = Q \\left( \\frac{C_{a}(t) (Q + PS) - \\left(Q C_{a}(t) + PS \\frac{C_{t,u}(t)}{K_{p}}\\right)}{Q + PS} \\right)$$\nExpanding the numerator:\n$$\\text{Net Diffusive Flux} = Q \\left( \\frac{Q C_{a}(t) + PS C_{a}(t) - Q C_{a}(t) - PS \\frac{C_{t,u}(t)}{K_{p}}}{Q + PS} \\right)$$\nThe $Q C_{a}(t)$ terms cancel out:\n$$\\text{Net Diffusive Flux} = Q \\left( \\frac{PS C_{a}(t) - PS \\frac{C_{t,u}(t)}{K_{p}}}{Q + PS} \\right)$$\nFactoring out $PS$ from the numerator:\n$$\\text{Net Diffusive Flux} = \\frac{Q \\cdot PS}{Q + PS} \\left( C_{a}(t) - \\frac{C_{t,u}(t)}{K_{p}} \\right)$$\n\nThis expression for the net flux is derived from the first principles given in the problem. We now compare this result with the definitional equation for $CL_{\\text{tissue}}$ (5):\n$$\\frac{dA_{t}(t)}{dt} = \\text{Net Diffusive Flux} = CL_{\\text{tissue}} \\left( C_{a}(t) - \\frac{C_{t,u}(t)}{K_{p}} \\right)$$\nBy direct comparison of the two expressions for the Net Diffusive Flux, one derived from first principles and the other from the definition of $CL_{\\text{tissue}}$, we can identify the expression for $CL_{\\text{tissue}}$:\n$$CL_{\\text{tissue}} = \\frac{Q \\cdot PS}{Q + PS}$$\nNote that the tissue partition coefficient $K_{p}$ does not appear in the final expression for $CL_{\\text{tissue}}$. This is because the problem defined $CL_{\\text{tissue}}$ relative to a driving force, $C_{a}(t) - C_{t,u}(t)/K_{p}$, that already accounts for the equilibrium partitioning behavior.\n\nNext, we analyze the expression for $CL_{\\text{tissue}}$ to determine the regimes of exchange. The expression can be rewritten as:\n$$CL_{\\text{tissue}} = \\frac{1}{\\frac{Q+PS}{Q \\cdot PS}} = \\frac{1}{\\frac{1}{PS} + \\frac{1}{Q}}$$\nThis form shows that the total resistance to tissue uptake, $1/CL_{\\text{tissue}}$, is the sum of a permeability-related resistance, $1/PS$, and a perfusion-related resistance, $1/Q$. The overall clearance is the harmonic mean of $Q$ and $PS$.\n\nThe criterion demarcating the limiting behaviors depends on the relative magnitudes of $Q$ and $PS$:\n1.  **Perfusion-limited regime**: This occurs when permeability is very high compared to blood flow, i.e., $PS \\gg Q$. In this case, the membrane presents a negligible barrier to diffusion. The term $1/PS$ becomes negligible compared to $1/Q$.\n    $$PS \\gg Q \\implies Q+PS \\approx PS$$\n    $$CL_{\\text{tissue}} = \\frac{Q \\cdot PS}{Q + PS} \\approx \\frac{Q \\cdot PS}{PS} = Q$$\n    In this regime, the tissue clearance is approximately equal to the blood flow, meaning drug uptake is limited by the rate of delivery to the tissue.\n\n2.  **Permeability-limited regime**: This occurs when blood flow is very high compared to permeability, i.e., $Q \\gg PS$. In this case, there is an abundant supply of the drug, but its passage across the endothelial barrier is slow. The term $1/Q$ becomes negligible compared to $1/PS$.\n    $$Q \\gg PS \\implies Q+PS \\approx Q$$\n    $$CL_{\\text{tissue}} = \\frac{Q \\cdot PS}{Q + PS} \\approx \\frac{Q \\cdot PS}{Q} = PS$$\n    In this regime, the tissue clearance is approximately equal to the permeability-surface area product, meaning drug uptake is limited by the rate of diffusion across the capillary wall.\n\nTherefore, the criterion demarcating the two behaviors is the comparison of $PS$ and $Q$. The system is perfusion-limited when $PS \\gg Q$ and permeability-limited when $PS \\ll Q$. The transition between these regimes occurs when $PS$ and $Q$ are of a similar order of magnitude.",
            "answer": "$$\\boxed{\\frac{Q \\cdot PS}{Q + PS}}$$"
        },
        {
            "introduction": "The predictive power of QSP models hinges on their ability to integrate data across multiple biological scales, from molecular interactions to whole-body outcomes. A common task is to characterize the activity of drug transporters, which often follow saturable Michaelis-Menten kinetics and can be subject to competitive inhibition by other compounds. In this problem , you will apply these principles to a practical scenario: calculating the whole-liver uptake rate of a drug in the presence of an inhibitor. This exercise demonstrates the crucial QSP workflow of scaling quantitative data from an *in vitro* cellular system (pmol/min per million hepatocytes) to predict the metabolic or transport activity at the entire organ level ($\\mu\\text{mol}/\\text{min}$), forming a vital bridge between experimental measurement and physiological simulation.",
            "id": "5053557",
            "problem": "A drug is taken up into human hepatocytes by a single saturable sinusoidal transporter under conditions relevant to Quantitative Systems Pharmacology (QSP). Assume a well-stirred sinusoidal blood compartment so that the extracellular drug concentration is uniform and constant over the short time window of interest. The transporter binds the drug competitively with a co-administered inhibitor. The mechanistic basis is as follows: the transporter ($T$) binds the substrate ($S$) and the inhibitor ($I$) reversibly, and bound substrate is translocated into the cell with a catalytic turnover. Under the quasi-steady-state approximation and the Law of Mass Action, the uptake rate depends on the total transporter content and the relative binding of $S$ and $I$.\n\nHepatocyte-scaled parameters measured in vitro are provided as follows. The maximal uptake capacity per $10^{6}$ hepatocytes is $V_{\\max,h} = 80\\,\\text{pmol}/\\text{min}$ per $10^{6}$ cells. The Michaelis constant for the substrate is $K_{m} = 15\\,\\mu\\text{M}$. The competitive inhibition constant for the inhibitor is $K_{i} = 20\\,\\mu\\text{M}$. In vivo, consider a liver of mass $M_{L} = 1500\\,\\text{g}$ containing $n_{h} = 1.2 \\times 10^{8}$ hepatocytes per gram of liver. The extracellular (sinusoidal) drug concentration is $C = 5\\,\\mu\\text{M}$ and the inhibitor concentration is $I = 10\\,\\mu\\text{M}$ throughout the sinusoid.\n\nStarting from mass-action binding and turnover for $T$, $S$, and $I$, use the quasi-steady-state approximation to derive the saturable uptake rate with competitive inhibition and scale it from per-hepatocyte to the whole liver. Compute the whole-liver uptake rate given the values above. Express the final rate in $\\mu\\text{mol}/\\text{min}$ and round your answer to four significant figures.",
            "solution": "The problem statement is evaluated as scientifically grounded, well-posed, and objective. All necessary parameters are provided, and the requested task is a standard calculation in quantitative systems pharmacology, involving the derivation of a kinetic equation, scaling of parameters from in vitro to in vivo, and a final numerical computation. The problem is valid.\n\nThe solution proceeds in three stages:\n1.  Derivation of the uptake rate equation for competitive inhibition using the quasi-steady-state approximation (QSSA).\n2.  Scaling of the maximal velocity ($V_{\\max}$) from the in vitro hepatocyte system to the whole liver.\n3.  Calculation of the whole-liver uptake rate using the provided parameters.\n\n**1. Derivation of the Rate Equation**\n\nLet $T$ represent the free transporter, $S$ the substrate (drug), and $I$ the competitive inhibitor. The substrate binds to the transporter to form the complex $TS$, which is then translocated. The inhibitor binds to the free transporter to form the complex $TI$, which is inactive. The reactions are:\n$$T + S \\underset{k_{-1}}{\\stackrel{k_1}{\\rightleftharpoons}} TS \\stackrel{k_{\\text{cat}}}{\\longrightarrow} T + \\text{Product}_{\\text{in-cell}}$$\n$$T + I \\underset{k_{-i}}{\\stackrel{k_i}{\\rightleftharpoons}} TI$$\n\nThe total concentration of the transporter is constant:\n$$[T]_{\\text{total}} = [T] + [TS] + [TI]$$\n\nThe rate of substrate uptake, $v$, is determined by the catalytic turnover of the $TS$ complex:\n$$v = k_{\\text{cat}}[TS]$$\n\nThe maximal rate, $V_{\\max}$, is achieved when all transporters are saturated with substrate, so $[TS] = [T]_{\\text{total}}$ (in the absence of inhibitor). Thus, $V_{\\max} = k_{\\text{cat}}[T]_{\\text{total}}$.\n\nUnder the quasi-steady-state approximation for the substrate-transporter complex, the rate of formation of $[TS]$ equals its rate of breakdown:\n$$\\frac{d[TS]}{dt} = k_1[T][S] - (k_{-1} + k_{\\text{cat}})[TS] = 0$$\n$$k_1[T][S] = (k_{-1} + k_{\\text{cat}})[TS]$$\nRearranging gives:\n$$[TS] = \\frac{k_1}{k_{-1} + k_{\\text{cat}}}[T][S] = \\frac{[T][S]}{K_m}$$\nwhere $K_m = \\frac{k_{-1} + k_{\\text{cat}}}{k_1}$ is the Michaelis-Menten constant.\n\nThe inhibitor binding is assumed to be in rapid equilibrium, characterized by the dissociation constant $K_i$:\n$$K_i = \\frac{[T][I]}{[TI]}$$\nFrom this, the concentration of the transporter-inhibitor complex is:\n$$[TI] = \\frac{[T][I]}{K_i}$$\n\nNow, substitute the expressions for $[TS]$ and $[TI]$ into the total transporter conservation equation:\n$$[T]_{\\text{total}} = [T] + \\frac{[T][S]}{K_m} + \\frac{[T][I]}{K_i}$$\nFactor out the free transporter concentration $[T]$:\n$$[T]_{\\text{total}} = [T] \\left( 1 + \\frac{[S]}{K_m} + \\frac{[I]}{K_i} \\right)$$\nSolving for $[T]$:\n$$[T] = \\frac{[T]_{\\text{total}}}{1 + \\frac{[S]}{K_m} + \\frac{[I]}{K_i}}$$\n\nSubstitute this expression for $[T]$ back into the equation for $[TS]$:\n$$[TS] = \\frac{[S]}{K_m} [T] = \\frac{[S]}{K_m} \\left( \\frac{[T]_{\\text{total}}}{1 + \\frac{[S]}{K_m} + \\frac{[I]}{K_i}} \\right)$$\n\nFinally, the uptake rate $v$ is found by substituting this expression for $[TS]$ into $v = k_{\\text{cat}}[TS]$:\n$$v = k_{\\text{cat}} \\frac{[S]}{K_m} \\left( \\frac{[T]_{\\text{total}}}{1 + \\frac{[S]}{K_m} + \\frac{[I]}{K_i}} \\right) = \\frac{k_{\\text{cat}}[T]_{\\text{total}}[S]}{K_m \\left( 1 + \\frac{[S]}{K_m} + \\frac{[I]}{K_i} \\right)}$$\nUsing $V_{\\max} = k_{\\text{cat}}[T]_{\\text{total}}$ and identifying the substrate concentration $[S]$ with $C$:\n$$v = \\frac{V_{\\max} C}{K_m + C + K_m \\frac{I}{K_i}}$$\nThis can be rearranged into the standard form for competitive inhibition:\n$$v = \\frac{V_{\\max} C}{K_m \\left(1 + \\frac{I}{K_i}\\right) + C}$$\n\n**2. Scaling of Maximal Velocity to the Whole Liver**\n\nFirst, calculate the total number of hepatocytes in the liver, $N_{h, \\text{total}}$.\nGiven liver mass $M_L = 1500\\,\\text{g}$ and hepatocyte density $n_h = 1.2 \\times 10^8$ hepatocytes/g.\n$$N_{h, \\text{total}} = M_L \\times n_h = (1500\\,\\text{g}) \\times (1.2 \\times 10^8\\,\\text{cells/g}) = 1.8 \\times 10^{11} \\text{ cells}$$\n\nNext, scale the maximal uptake capacity $V_{\\max,h}$ to the entire liver. $V_{\\max,h} = 80\\,\\text{pmol}/\\text{min}$ per $10^6$ cells. The whole-liver maximal uptake rate, $V_{\\max,L}$, is:\n$$V_{\\max,L} = V_{\\max,h} \\times \\frac{N_{h, \\text{total}}}{10^6\\,\\text{cells}} = (80\\,\\text{pmol}/\\text{min}) \\times \\frac{1.8 \\times 10^{11}}{10^6} = 80 \\times 1.8 \\times 10^5\\,\\text{pmol}/\\text{min}$$\n$$V_{\\max,L} = 144 \\times 10^5\\,\\text{pmol}/\\text{min} = 1.44 \\times 10^7\\,\\text{pmol}/\\text{min}$$\n\nThe problem requires the final answer in $\\mu\\text{mol}/\\text{min}$. We convert the units of $V_{\\max,L}$:\n$$V_{\\max,L} = (1.44 \\times 10^7\\,\\text{pmol}/\\text{min}) \\times \\left(\\frac{1\\,\\mu\\text{mol}}{10^6\\,\\text{pmol}}\\right) = 14.4\\,\\mu\\text{mol}/\\text{min}$$\n\n**3. Calculation of Whole-Liver Uptake Rate**\n\nWe now use the derived rate equation with the whole-liver $V_{\\max,L}$ and the provided concentrations. The parameters are:\n- $V_{\\max,L} = 14.4\\,\\mu\\text{mol}/\\text{min}$\n- $C = 5\\,\\mu\\text{M}$\n- $I = 10\\,\\mu\\text{M}$\n- $K_m = 15\\,\\mu\\text{M}$\n- $K_i = 20\\,\\mu\\text{M}$\n\nLet $v_L$ be the whole-liver uptake rate:\n$$v_L = \\frac{V_{\\max,L} C}{K_m \\left(1 + \\frac{I}{K_i}\\right) + C}$$\nSubstitute the numerical values:\n$$v_L = \\frac{(14.4\\,\\mu\\text{mol}/\\text{min}) \\times (5\\,\\mu\\text{M})}{(15\\,\\mu\\text{M}) \\left(1 + \\frac{10\\,\\mu\\text{M}}{20\\,\\mu\\text{M}}\\right) + 5\\,\\mu\\text{M}}$$\nThe concentration units $(\\mu\\text{M})$ cancel out in the fraction, leaving the rate in $\\mu\\text{mol}/\\text{min}$.\n$$v_L = \\frac{14.4 \\times 5}{15 \\left(1 + 0.5\\right) + 5}\\,\\mu\\text{mol}/\\text{min}$$\n$$v_L = \\frac{72}{15 \\times 1.5 + 5}\\,\\mu\\text{mol}/\\text{min}$$\n$$v_L = \\frac{72}{22.5 + 5}\\,\\mu\\text{mol}/\\text{min}$$\n$$v_L = \\frac{72}{27.5}\\,\\mu\\text{mol}/\\text{min}$$\n$$v_L \\approx 2.618181... \\,\\mu\\text{mol}/\\text{min}$$\n\nRounding the result to four significant figures as requested gives $2.618\\,\\mu\\text{mol}/\\text{min}$.",
            "answer": "$$\\boxed{2.618}$$"
        }
    ]
}